5th Circuit Bans Mifepristone Mail Distribution; Drugmakers Rush to Supreme CourtMay 16, 2026Legal NewsThe Fifth Circuit voided FDA's 2021 mail-dispensing rule for mifepristone, banning telehealth prescribing nationwide. The Supreme Court issued an emergency stay May 14.
Supreme Court Stays Fifth Circuit Mifepristone Ruling, Preserving Telehealth AccessMay 16, 2026Legal NewsThe Supreme Court stayed the Fifth Circuit's mifepristone telehealth ban on May 14, preserving mail-order access while two justices raised the Comstock Act as a future threat.
Supreme Court Stays Fifth Circuit Order on Mifepristone Dispensing RulesMay 16, 2026Legal NewsThe Supreme Court stayed a Fifth Circuit order reinstating in-person mifepristone rules, preserving telehealth access while signaling Comstock Act tensions ahead.
Supreme Court Blocks Fifth Circuit Order Restricting Mail-Order Mifepristone AccessMay 15, 2026Legal NewsThe Supreme Court stayed a Fifth Circuit ruling that would have banned mail-order mifepristone, with seven justices granting relief and Alito dissenting in sharp terms.
Fifth Circuit Blocks Mifepristone Mail Access, Drugmakers Rush to Supreme CourtMay 14, 2026Legal NewsThe Fifth Circuit ordered the FDA to reinstate in-person dispensing rules for mifepristone, blocking mail and telehealth access nationally. Drugmakers filed emergency Supreme Court applications.
Fifth Circuit Blocks Mifepristone Telehealth Access; Supreme Court IntervenesMay 14, 2026Legal NewsA Fifth Circuit panel reinstated mifepristone's in-person dispensing rule nationwide; Justice Alito issued successive emergency stays as the full Supreme Court deliberated.
Alito Issues One-Week Stay Blocking Fifth Circuit Mifepristone RulingMay 6, 2026Law and PolicyJustice Alito issued a one-week administrative stay on May 4, 2026, blocking a Fifth Circuit ruling that would have banned mail-order mifepristone access nationwide.